Evidence map›Paper›PMID 28537420›Full record

ArticleAntioxidants & redox signaling2018

Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75

Mi Jin Kim, Marcelo R Vargas, Benjamin A Harlan, Kelby M Killoy, Lauren E Ball, Susana Comte-Walters, Monika Gooz, Yasuhiko Yamamoto, Joseph S Beckman, Luis Barbeito and 1 more

Open access · greenAbstract read
In one paragraph

Article in Antioxidants & redox signaling, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Modulation of Aging Diseases via RAGE Targets: A Dietary Intervention Review.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Mi Jin Kim1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina , Charleston, South Carolina.
Marcelo R Vargas1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina , Charleston, South Carolina.
Benjamin A Harlan1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina , Charleston, South Carolina.
Kelby M Killoy1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina , Charleston, South Carolina.
Lauren E Ball1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina , Charleston, South Carolina.
Susana Comte-Walters1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina , Charleston, South Carolina.
Monika Gooz2 Department of Drug Discovery and Biomedical Sciences, Medical University of South Carolina , Charleston, South Carolina.
Yasuhiko Yamamoto3 Department of Biochemistry and Molecular Vascular Biology, Kanazawa University Graduate School of Medical Sciences , Kanazawa, Japan .
Joseph S Beckman4 Department of Biochemistry and Biophysics, Linus Pauling Institute, Environmental Health Sciences Center, Oregon State University , Corvallis, Oregon.
Luis Barbeito5 Institut Pasteur de Montevideo , Montevideo, Uruguay .
Mariana Pehar1 Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina , Charleston, South Carolina.
Medical University of South Carolina · USInstitut Pasteur de Montevideo · UYKanazawa University · JPOregon State University · US

Funding

SOUTH CAROLINA COBRE IN OXIDANTS, REDOX BALANCE AND STRESS SIGNALINGP20GM103542 · NIGMS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TEW, KENNETH D. · 2012 to 2020
$20.2M
NGF and RAGE-p75NTR signaling in models of amyotrophic lateral sclerosisR01NS100835 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI PEHAR, MARIANA ATINA · 2017 to 2021
$1.6M
Orbitrap Mass SpectrometerS10OD010731 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALL, LAUREN ELIZABETH · 2012 to 2012
$600k
NIGMS NIH HHS P20 GM103542NINDS NIH HHS R01 NS100835
6 · The paper itself

Abstract

introductionGlycating stress can occur together with oxidative stress during neurodegeneration and contribute to the pathogenic mechanism. Nerve growth factor (NGF) accumulates in several neurodegenerative diseases. Besides promoting survival, NGF can paradoxically induce cell death by signaling through the p75 neurotrophin receptor (p75

aimsHere we investigated whether glycation also changes the ability of NGF to induce cell death and assessed the ability of post-translational modified NGF to signal through the receptor for advanced glycation end products (RAGEs). We also explored the potential role of RAGE-p75

resultsGlycation promoted NGF oligomerization and ultimately allowed the modified neurotrophin to signal through RAGE and p75 INNOVATION: Oxidative modifications occurring under stress conditions can enhance the ability of mature NGF to induce neuronal death at physiologically relevant concentrations, and RAGE is a new p75

conclusionOur results indicate that NGF-RAGE/p75

Indexed as

Signal TransductionAmyotrophic Lateral SclerosisAnimalsCells, CulturedHumansMiceMice, Inbred C57BLMice, TransgenicMotor NeuronsNerve Growth FactorReceptor for Advanced Glycation End ProductsReceptor, Nerve Growth FactorNerve Growth FactorReceptor for Advanced Glycation End ProductsReceptor, Nerve Growth FactorALSglycationmotor neuronNGFp75NTRRAGE

Identifiers

PMID28537420
PMCPMC5962334
OpenAlexW2618430594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.